Vertex starts gene therapy Casgevy in five patients 

Off Alzheimer's disease, Alzheimer’s, Biotech, biotechnology, Business, drug development, drug prices, drug pricing, FDA, finance, government agencies, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, policy, Politics, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning, incredibly exciting news from the STAT newsroom — two of our reporters, Casey Ross and Bob Herman (or as we call them, Bob Ross), were named Pulitzer finalists in investigative reporting!

Read the rest…

Read Original Article: Vertex starts gene therapy Casgevy in five patients  »

About The Author